| Lactose (India) Ltd | 126 Cr. | 100 | 210/84.3 | 28.0 | 49.6 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.36 Cr. | 1.76 | 4.29/1.76 | | 0.33 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 4,407 Cr. | 404 | 479/192 | 91.3 | 24.3 | 0.17 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 34.9 Cr. | 47.0 | 87.8/37.2 | | 10.6 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 58.0 Cr. | 39.6 | 41.0/17.0 | 138 | 6.93 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 65.0 Cr. | 86.3 | 119/69.7 | 17.6 | 60.3 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 58,692 Cr. | 2,080 | 2,286/1,275 | 23.4 | 340 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 331 Cr. | 13.6 | 17.8/10.8 | 19.8 | 8.79 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 6.90 Cr. | 11.7 | 17.6/9.25 | 86.2 | 14.0 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 794 Cr. | 1,479 | 1,999/635 | 27.5 | 334 | 0.05 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 93.3 Cr. | 18.7 | 32.0/17.0 | 25.5 | 10.8 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 990 Cr. | 336 | 449/219 | 8.84 | 133 | 0.74 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 3.05 Cr. | 14.5 | 39.0/13.0 | | 19.2 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 7.97 Cr. | 3.20 | 8.28/2.11 | 4.53 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 485 Cr. | 499 | 536/211 | 73.2 | 74.7 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 5,074 Cr. | 1,167 | 1,565/944 | 45.9 | 406 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 55.2 Cr. | 0.27 | 1.12/0.24 | 3.63 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 41.5 Cr. | 15.8 | 26.3/11.4 | 20.2 | 24.5 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 8.78 Cr. | 8.70 | 15.9/8.50 | | 19.0 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 162 Cr. | 454 | 851/429 | 9.19 | 596 | 0.33 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 87.2 Cr. | 87.2 | 92.5/26.1 | 164 | 34.4 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 14,088 Cr. | 1,346 | 2,452/1,297 | 43.8 | 174 | 0.80 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 25.1 Cr. | 55.0 | 88.7/36.1 | 54.6 | 21.6 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 13.2 Cr. | 5.29 | 7.66/2.97 | | 13.0 | 0.00 % | 10.6 % | 30.3 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 20.2 Cr. | 135 | 153/63.0 | | 9.60 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 70.7 Cr. | 129 | 144/9.41 | 48.8 | 3.60 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 29.6 Cr. | 39.2 | 73.0/33.0 | 47.7 | 40.3 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 6.69 Cr. | 22.3 | 25.4/15.5 | | 12.3 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 8,888 Cr. | 513 | 1,028/511 | 25.2 | 72.4 | 0.23 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 83.6 Cr. | 19.4 | 30.5/18.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 11.5 Cr. | 22.6 | 43.0/17.4 | 49.9 | 18.6 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 93,352 Cr. | 2,261 | 2,883/2,090 | 56.0 | 376 | 0.04 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 237 Cr. | 411 | 524/241 | 24.3 | 123 | 1.09 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 61.3 Cr. | 42.7 | 47.9/26.7 | 95.8 | 18.4 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 70,056 Cr. | 1,206 | 1,295/994 | 20.5 | 603 | 0.33 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 141 Cr. | 226 | 303/159 | 134 | 69.9 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 774 Cr. | 77.6 | 115/74.0 | 20.0 | 32.6 | 1.93 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 36.6 Cr. | 28.1 | 44.9/21.0 | | 50.0 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 14,229 Cr. | 1,737 | 1,902/919 | 63.5 | 173 | 0.09 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 4.03 Cr. | 0.61 | 1.24/0.51 | 101 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 213 Cr. | 27.8 | 57.0/26.0 | 13.7 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 5.94 Cr. | 10.2 | 20.1/7.60 | | 2.75 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 136 Cr. | 5.78 | 6.57/2.82 | 317 | 1.34 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 60,204 Cr. | 28,340 | 37,000/25,260 | 39.9 | 1,888 | 1.68 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 6,616 Cr. | 730 | 972/557 | 27.6 | 226 | 0.68 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 193 Cr. | 67.8 | 100/31.3 | 54.0 | 52.5 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 4,853 Cr. | 1,463 | 1,740/752 | | 103 | 0.07 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 23,690 Cr. | 1,458 | 1,870/1,110 | 432 | 281 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 761 Cr. | 219 | 330/154 | 17.7 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 91.9 Cr. | 11.1 | 29.4/11.0 | | 5.79 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 952 Cr. | 708 | 849/270 | 15.0 | 445 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 2,973 Cr. | 422 | 791/418 | 20.4 | 346 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,414 Cr. | 1,005 | 1,402/991 | 20.0 | 768 | 1.00 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,36,303 Cr. | 4,026 | 4,106/2,886 | 62.9 | 250 | 0.79 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 925 Cr. | 100 | 284/98.0 | | 41.3 | 0.50 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,273 Cr. | 13.6 | 23.5/13.5 | 20.3 | 4.00 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 18,951 Cr. | 496 | 1,328/488 | 55.2 | 99.0 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 3,737 Cr. | 164 | 303/102 | | 12.4 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 4,22,475 Cr. | 1,761 | 1,851/1,547 | 36.6 | 324 | 0.91 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,038 Cr. | 561 | 734/441 | 318 | 347 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 3,216 Cr. | 343 | 360/175 | 39.6 | 81.2 | 0.12 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 357 Cr. | 1,197 | 1,680/956 | 20.6 | 650 | 0.13 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 5,979 Cr. | 306 | 502/265 | 38.6 | 125 | 0.16 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 8,721 Cr. | 200 | 260/111 | 202 | 32.2 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 9,579 Cr. | 4,159 | 6,718/4,050 | 25.9 | 340 | 2.81 % | 49.2 % | 47.2 % | 10.0 |
| RPG Life Sciences Ltd | 3,861 Cr. | 2,334 | 2,725/1,772 | 34.6 | 335 | 0.86 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 9,462 Cr. | 5,700 | 6,739/4,904 | 30.8 | 373 | 2.19 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 169 Cr. | 47.8 | 85.0/42.0 | | 14.7 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 21,986 Cr. | 4,806 | 5,993/3,701 | 31.1 | 841 | 0.73 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 120 Cr. | 97.2 | 210/81.0 | 12.4 | 86.5 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 2,648 Cr. | 432 | 582/281 | | 135 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 3,840 Cr. | 757 | 1,885/604 | 73.5 | 251 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 19,014 Cr. | 14,820 | 19,748/10,060 | 97.1 | 1,263 | 0.08 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 419 Cr. | 18.7 | 41.0/13.0 | | 32.0 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 16,294 Cr. | 910 | 1,341/660 | 10.6 | 483 | 0.66 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 2,223 Cr. | 40.6 | 71.4/38.4 | 29.4 | 21.8 | 0.49 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 8,105 Cr. | 179 | 276/162 | 23.0 | 59.3 | 0.45 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 58.3 Cr. | 36.8 | 130/22.7 | | 80.5 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 283 Cr. | 79.2 | 164/72.2 | 139 | 28.3 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 1,00,080 Cr. | 2,191 | 2,263/1,774 | 23.1 | 430 | 0.55 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 968 Cr. | 484 | 838/464 | 12.1 | 357 | 0.37 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 59,433 Cr. | 1,101 | 1,141/501 | 87.0 | 91.1 | 0.11 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 1,133 Cr. | 1,092 | 1,235/596 | 23.1 | 281 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 144 Cr. | 66.8 | 114/63.6 | | 73.2 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 735 Cr. | 152 | 216/123 | 41.8 | 104 | 1.97 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 589 Cr. | 337 | 500/265 | 21.4 | 152 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 17,117 Cr. | 1,074 | 1,250/802 | 34.4 | 414 | 0.47 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 29,936 Cr. | 1,911 | 1,939/1,303 | 41.7 | 243 | 0.81 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,254 Cr. | 187 | 302/185 | 28.7 | 38.0 | 1.33 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 39,172 Cr. | 1,544 | 1,673/1,168 | 39.6 | 293 | 0.26 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,343 Cr. | 79.8 | 127/57.5 | 20.2 | 59.7 | 1.00 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 28.8/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 745 Cr. | 91.2 | 124/67.2 | 25.1 | 160 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 2,043 Cr. | 222 | 350/190 | | 106 | 0.09 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 2,691 Cr. | 218 | 457/217 | 266 | 96.9 | 0.64 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,353 Cr. | 1,590 | 2,359/1,243 | 30.8 | 397 | 0.44 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 3,249 Cr. | 324 | 486/285 | 59.8 | 62.7 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 14,738 Cr. | 607 | 627/412 | 28.8 | 164 | 0.25 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 58,692 Cr. | 2,080 | 2,286/1,275 | 23.4 | 340 | 0.12 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 40,635 Cr. | 2,399 | 3,516/1,921 | 42.6 | 101 | 1.75 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 27,923 Cr. | 1,695 | 2,131/1,200 | 24.2 | 610 | 1.06 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 6,551 Cr. | 402 | 528/359 | 29.1 | 149 | 1.24 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 20,901 Cr. | 1,534 | 1,910/1,097 | 50.3 | 227 | 0.48 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,00,732 Cr. | 1,207 | 1,386/1,020 | 17.4 | 432 | 0.66 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 4,060 Cr. | 259 | 322/178 | 27.2 | 406 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,17,983 Cr. | 1,461 | 1,673/1,310 | 21.7 | 408 | 0.89 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 13,826 Cr. | 1,819 | 2,466/1,551 | 23.5 | 416 | 0.33 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 220 Cr. | 74.7 | 185/68.1 | 15.8 | 39.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 1,927 Cr. | 182 | 196/105 | 17.6 | 107 | 0.27 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 54.0 Cr. | 33.2 | 62.9/32.2 | 19.0 | 13.1 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 50,531 Cr. | 378 | 425/291 | 106 | 200 | 0.13 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,651 Cr. | 1,636 | 2,000/1,430 | 36.5 | 219 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 116 Cr. | 72.7 | 129/67.2 | 17.0 | 49.2 | 1.65 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 332 Cr. | 140 | 205/67.8 | 31.4 | 38.6 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 21,046 Cr. | 8,418 | 10,691/6,502 | 91.0 | 320 | 0.38 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 1,823 Cr. | 632 | 843/544 | 32.2 | 118 | 0.73 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 159 Cr. | 75.6 | 137/73.6 | 8.44 | 92.0 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 69,458 Cr. | 5,793 | 5,868/4,492 | 29.6 | 1,116 | 0.78 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 16,032 Cr. | 815 | 1,108/725 | 25.3 | 271 | 1.35 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 431 Cr. | 750 | 1,338/730 | | 690 | 0.67 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 35,473 Cr. | 2,838 | 3,080/2,022 | 36.4 | 345 | 0.99 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,374 Cr. | 301 | 367/258 | 22.9 | 133 | 1.73 % | 13.1 % | 9.54 % | 2.00 |
| Aarti Drugs Limited | 3,583 Cr. | 393 | 575/312 | 18.8 | 147 | 0.25 % | 13.5 % | 13.0 % | 10.0 |
| Industry Average | 20,547.27 Cr | 1,144.30 | | 52.87 | 202.18 | 0.35% | 16.29% | 15.20% | 6.10 |